Next Generation Sequencing Market

Next Generation Sequencing Market / NGS Market by Product & Service (Consumables, Platforms, Services), Technology (SBS, Nanopore), Application (Diagnostic, Drug Discovery, Agriculture), End User (Pharma, Biotech, Academic) & Region - Global Forecast to 2027

Report Code: BT 2697 Jan, 2023, by marketsandmarkets.com

The global next generation sequencing market in terms of revenue was estimated to be worth $13 billion in 2022 and is poised to reach $27 billion by 2027, growing at a CAGR of 15.7% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

The growth of the market is attributed to declining costs of genome sequencing, growing incidence of cancer, and launch of new NGS platforms.

Attractive Opportunities in the Next-generation Sequencing Market

Next Generation Sequencing Market

To know about the assumptions considered for the study, Request for Free Sample Report

Next Generation Sequencing Market Dynamics

Driver: Advancements in NGS platforms

In last few years, prominent market players have introduced new technologies behind them provides an immediate competitive edge to players. Market players are now focusing on the increasing their R&D efforts in development of new product. PromethION (Oxford Nanopore Technologies), Ion Torrent Genexus Dx Integrated Sequencer (Thermo Fisher), iSeq 100 (Illumina), and Ion GeneStudio S5 System (Thermo Fisher) are the key revolutionary platforms in the market.

Restraint: End-user budget constraints in developing countries

Academic R&D in developing nations is mostly dependent on external funding. Despite continuous efforts by government and private bodies to provide funds for research across the globe, various research and academic institutes are facing budget constraints when it comes to the purchase and use of advanced and premium-priced equipment and technologies. As a result, the installation/expansion of advanced research facilities is hampered in academic and research institutes in developing nations. This is a key hindrance to the adoption of technologies such as NGS in developing nations across Africa and Asia.

Opportunity: Application of NGS in precision medicine and molecular diagnostics

Continuous developments in sequencing technologies and a better understanding of genomics have increased the efficiency of biomarkers in disease detection. Since precise diagnosis and personalized medicine increase survival rates as well as reduce the financial burden on national health insurance programs, governments across the globe are expected to make significant investments in genome sciences, which will ensure a positive future demand for NGS in such applications.

Consumables accounted for the largest share of next generation sequencing industry

Next generation sequencing market by product & services is categorized into pre-sequencing products & services, NGS platforms, NGS consumables, services for NGS platforms, sequencing services, and bioinformatics. NGS consumables dominated the market in 2021. Various factors contributing to the growth of the segment are increasing demand for kits and reagents for sequencing procedures.

North America was the largest regional market for next generation sequencing industry

The next generation sequencing (NGS) market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share of the market. Increasing number of genomics research projects, rising demand for new NGS platforms and growing use of NGS consumables are various factors projected to drive the growth of the market.

Next Generation Sequencing Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Illumina (US), Thermo Fisher Scientific (US), PerkinElmer (US), BGI Group (China), and Agilent Technologies (US), are the prominent players operating in the next generation sequencing market.

Scope of the Next Generation Sequencing Industry

Report Metric 

Details 

Market Revenue in 2022

$13 billion

Projected Revenue by 2027

$27 billion

Revenue Rate

Poised to Grow at a CAGR of 15.7%

Market Driver

Advancements in NGS platforms

Market Opportunity

Application of NGS in precision medicine and molecular diagnostics

The study categorizes the next generation sequencing market to forecast revenue and analyze trends in each of the following submarkets:

By Product

  • NGS Consumables
  • Sequencing Services
    • Exome & Targeted Resequencing and Custom Panels
    • RNA Sequencing
    • De Novo Sequencing
    • ChIP-Seq
    • Whole-genome Sequencing
    • Methyl Sequencing
    • Other Sequencing Services
  • Presequencing Products & Services
    • Library Preparation & Target Enrichment
    • Quality Control
  • NGS Platforms
    • Illumina
      • Novaseq Systems
      • Nextseq Systems
      • Miseq Systems
      • Miniseq Systems
      • iSeq Systems
    • Thermo Fisher Scientific
      • ION PGM Systems
      • ION Proton Systems
      • ION Genestudio Systems
      • Ion Torrent Genexus Systems
    • Oxford Nanopore Technologies
    • Pacific Biosciences
    • Other Platforms
  • Bioinformatics
    • Data Analysis Services
    • NGS Data Analysis Software & Workbenches
    • NGS Storage, Management, & Cloud Computing Solutions
  • Services for NGS Platforms

By Technology

  • Sequencing by Synthesis
  • ION Semiconductor Sequencing
  • Nanopore Sequencing
  • Single-Molecule Real-Time Sequencing
  • Other Technologies

By Application

  • Diagnostics
    • Cancer Diagnostics
    • Infectious Disease Diagnostics
    • Reproductive Health Diagnostics
    • Other Diagnostic Applications
  • Drug Discovery & Development
    • Pharmacogenomics
    • Other Drug Discovery and Development Applications
  • Agricultural & Animal Research
  • Other Applications

By End User

  • Academic Institutes & Research Centers
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Clinics
  • Reference Laboratories
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Netherlands
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • Middle East
    • Africa

Recent Developments of Next Generation Sequencing Industry

  • In October 2022, Illumina (US) and GenoScreen (France) partnered to expand access to genomic testing for multidrug-resistant tuberculosis in countries most impacted by tuberculosis.
  • In October 2022, Illumina (US) entered a strategic research collaboration with AstraZeneca (UK) to improve the efficiency of pharma pipelines by leveraging the ability to identify genetic variants that contribute to human diseases.
  • In September 2022, Thermo Fisher Scientific (US) received FDA approval for the Oncomine Dx Target Test as the first NGS-based companion diagnostic to aid in therapy selection for patients with RET Mutations/Fusions in thyroid cancers.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 57)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
          FIGURE 1 NEXT GENERATION SEQUENCING MARKET SEGMENTATION
           1.3.1 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED 
    1.5 LIMITATIONS 
    1.6 STAKEHOLDERS 
    1.7 SUMMARY OF CHANGES 
 
2 RESEARCH METHODOLOGY (Page No. - 61)
    2.1 RESEARCH APPROACH 
          FIGURE 2 RESEARCH DESIGN
           2.1.1 PRIMARY RESEARCH
                    FIGURE 3 NEXT GENERATION SEQUENCING MARKET FORECAST: PRIMARY RESPONDENTS
    2.2 MARKET ESTIMATION METHODOLOGY 
          FIGURE 4 NEXT GENERATION SEQUENCING INDUSTRY SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2021
          FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2021
           2.2.1 INSIGHTS FROM PRIMARY EXPERTS
                    FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
    2.3 MARKET GROWTH RATE PROJECTIONS 
          FIGURE 7 MARKET: CAGR PROJECTIONS, 2022–2027
          FIGURE 8 (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
    2.4 DATA TRIANGULATION 
          FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.5 RESEARCH ASSUMPTIONS 
    2.6 RISK ANALYSIS 
    2.7 RECESSION IMPACT 
          TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
          TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
          TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
 
3 EXECUTIVE SUMMARY (Page No. - 72)
    FIGURE 10 NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)
    FIGURE 11 NEXT GENERATION SEQUENCING INDUSTRY, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)
    FIGURE 12 NGS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    FIGURE 13 NEXT GENERATION SEQUENCING MARKET SHARE, BY END USER, 2022 VS. 2027 (USD MILLION)
    FIGURE 14 GEOGRAPHICAL SNAPSHOT OF NEXT GENERATION SEQUENCING MARKET RESEARCH
 
4 PREMIUM INSIGHTS (Page No. - 77)
    4.1 NEXT GENERATION SEQUENCING MARKET OVERVIEW 
          FIGURE 15 ADVANCEMENTS IN NGS TECHNOLOGIES TO DRIVE GROWTH
    4.2 NORTH AMERICA: NEXT GENERATION SEQUENCING MARKET REPORT, BY PRODUCT & SERVICE AND COUNTRY (2021) 
          FIGURE 16 NGS CONSUMABLES ACCOUNTED FOR LARGEST MARKET SHARE IN 2021
    4.3 NEXT GENERATION SEQUENCING INDUSTRY SHARE, BY APPLICATION, 2022 VS. 2027 
          FIGURE 17 DIAGNOSTICS SEGMENT WILL CONTINUE TO DOMINATE MARKET IN 2027
    4.4 NEXT GENERATION SEQUENCING INDUSTRY: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 80)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 19 NEXT GENERATION SEQUENCING MARKET SHARE: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          TABLE 4 NEXT GENERATION SEQUENCING INDUSTRY: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Advancements in NGS platforms
                               5.2.1.1.1 PromethION 2 Solo
                               5.2.1.1.2 Ion Torrent Genexus Dx
                               5.2.1.1.3 iSeq 100 system
                               5.2.1.1.4 Ion GeneStudio S5
                    5.2.1.2 Declining cost of genome sequencing
                                FIGURE 20 COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001–2021
                    5.2.1.3 Improving regulatory and reimbursement scenarios for NGS-based diagnostic tests
                    5.2.1.4 Growing incidence of cancer and increasing applications of next-generation sequencing in cancer research
                                FIGURE 21 NUMBER OF NEW CANCER CASES WORLDWIDE, 2020
                                TABLE 5 CANCER INCIDENCE, 2020 VS. 2040
           5.2.2 RESTRAINTS
                    5.2.2.1 End-user budget constraints in developing countries
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Application of NGS in precision medicine and molecular diagnostics
                    5.2.3.2 Government and private support for large-scale sequencing
                                TABLE 6 GLOBAL SEQUENCING INITIATIVES
                    5.2.3.3 Advancements in NGS data analysis using big data
                                FIGURE 22 DATA PRODUCED DURING HUMAN WHOLE-GENOME SEQUENCING, 2001–2019
                    5.2.3.4 Development of portable sequencing technologies
                    5.2.3.5 Partnerships and collaborations for technological advancements in NGS
                                TABLE 7 PARTNERSHIPS AND COLLABORATIONS, JANUARY 2018–DECEMBER 2022
           5.2.4 CHALLENGES
                    5.2.4.1 Interpretation of complex data from NGS platforms
                    5.2.4.2 Ethical issues
                    5.2.4.3 Introduction of alternative technologies
    5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
          FIGURE 23 REVENUE SHIFT AND NEW REVENUE POCKETS
    5.4 PRICING ANALYSIS 
          TABLE 8 AVERAGE SELLING PRICE OF NGS SYSTEMS, BY KEY PLAYER (2021)
    5.5 TECHNOLOGY ANALYSIS 
          TABLE 9 SANGER SEQUENCING VS. NGS
    5.6 VALUE CHAIN ANALYSIS 
          FIGURE 24 VALUE CHAIN ANALYSIS OF : MARKET MANUFACTURING AND ASSEMBLY PHASES ADD MAXIMUM VALUE
          FIGURE 25 VALUE CHAIN OF NEXT-GENERATION SEQUENCING ANALYSIS WORKFLOW: MAXIMUM VALUE ADDED DURING SEQUENCING AND ANALYSIS PHASES
    5.7 ECOSYSTEM ANALYSIS 
          FIGURE 26 ECOSYSTEM ANALYSIS: MARKET
          TABLE 10 SUPPLY CHAIN ECOSYSTEM
    5.8 KEY CONFERENCES AND EVENTS IN 2023–2024 
          TABLE 11 NGS MARKET: LIST OF CONFERENCES AND EVENTS
    5.9 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 12 NEXT GENERATION SEQUENCING MARKET REPORT: PORTER’S FIVE FORCES ANALYSIS
           5.9.1 THREAT OF NEW ENTRANTS
           5.9.2 THREAT OF SUBSTITUTES
           5.9.3 BARGAINING POWER OF SUPPLIERS
           5.9.4 BARGAINING POWER OF BUYERS
           5.9.5 INTENSITY OF COMPETITIVE RIVALRY
    5.10 KEY STAKEHOLDERS AND BUYING CRITERIA 
           FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NGS PRODUCTS AND SERVICES
          FIGURE 28 BUYING CRITERIA FOR NGS PRODUCTS
    5.11 PATENT ANALYSIS 
           FIGURE 29 PATENT APPLICATIONS RELATED TO NGS MARKET, JANUARY 2012–DECEMBER 2022
    5.12 REGULATORY ANALYSIS 
           5.12.1 NORTH AMERICA
                    5.12.1.1 US
                                 TABLE 13 US FDA: MEDICAL DEVICE CLASSIFICATION
                                 TABLE 14 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                    5.12.1.2 Canada
           5.12.2 EUROPE
           5.12.3 ASIA PACIFIC
                    5.12.3.1 China
                                 TABLE 15 CHINA: CLASSIFICATION OF MEDICAL DEVICES
                    5.12.3.2 Japan
                    5.12.3.3 India
           5.12.4 LATIN AMERICA
           5.12.5 MIDDLE EAST
 
6 NEXT GENERATION SEQUENCING MARKET FORECAST, BY PRODUCT & SERVICE (Page No. - 105)
    6.1 INTRODUCTION 
          TABLE 16 NEXT GENERATION SEQUENCING INDUSTRY, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
    6.2 NGS CONSUMABLES 
           6.2.1 GROWING NUMBER OF SEQUENCING PROCEDURES TO PROPEL DEMAND FOR NGS CONSUMABLES
                    TABLE 17 NGS CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 18 NORTH AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 19 EUROPE: NGS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 20 ASIA PACIFIC: NGS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 21 LATIN AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 22 MIDDLE EAST & AFRICA: NGS CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.3 SEQUENCING SERVICES 
          TABLE 23 SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 24 SEQUENCING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
          TABLE 25 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 26 EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 27 ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 28 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 29 MIDDLE EAST & AFRICA: SEQUENCING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.1 EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS
                    6.3.1.1 Development of technologically advanced NGS products and services to propel growth
                                TABLE 30 EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 31 NORTH AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 32 EUROPE: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 33 ASIA PACIFIC: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 34 LATIN AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 35 MIDDLE EAST & AFRICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.2 RNA SEQUENCING
                    6.3.2.1 Launch of RNA sequencing services to drive growth
                                TABLE 36 RNA SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 37 NORTH AMERICA: RNA SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 38 EUROPE: RNA SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 39 ASIA PACIFIC: RNA SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 40 LATIN AMERICA: RNA SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 41 MIDDLE EAST & AFRICA: RNA SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.3 DE NOVO SEQUENCING
                    6.3.3.1 Rising awareness about advantages of De Novo sequencing to support growth
                                TABLE 42 DE NOVO SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 43 NORTH AMERICA: DE NOVO SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 44 EUROPE: DE NOVO SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 45 ASIA PACIFIC: DE NOVO SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 46 LATIN AMERICA: DE NOVO SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 47 MIDDLE EAST & AFRICA: DE NOVO SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.4 CHIP SEQUENCING
                    6.3.4.1 Increasing demand for ChIP sequencing services to propel growth
                                TABLE 48 CHIP SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 49 NORTH AMERICA: CHIP SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 50 EUROPE: CHIP SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 51 ASIA PACIFIC: CHIP SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 52 LATIN AMERICA: CHIP SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 53 MIDDLE EAST & AFRICA: CHIP SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.5 WHOLE-GENOME SEQUENCING
                    6.3.5.1 Reducing whole-genome sequencing costs to propel growth
                                TABLE 54 WHOLE-GENOME SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 55 NORTH AMERICA: WHOLE-GENOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 56 EUROPE: WHOLE-GENOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 57 ASIA PACIFIC: WHOLE-GENOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 58 LATIN AMERICA: WHOLE-GENOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 59 MIDDLE EAST & AFRICA: WHOLE-GENOME SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.6 METHYL SEQUENCING
                    6.3.6.1 Rising importance of DNA methylation in study of cancer to drive growth
                                TABLE 60 METHYL SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 61 NORTH AMERICA: METHYL SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 62 EUROPE: METHYL SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 63 ASIA PACIFIC: METHYL SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 64 LATIN AMERICA: METHYL SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 65 MIDDLE EAST & AFRICA: METHYL SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.7 OTHER SEQUENCING SERVICES
                    TABLE 66 OTHER SEQUENCING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 67 NORTH AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 68 EUROPE: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 69 ASIA PACIFIC: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 70 LATIN AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 71 MIDDLE EAST & AFRICA: OTHER SEQUENCING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.4 PRE-SEQUENCING PRODUCTS & SERVICES 
          TABLE 72 PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 73 PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
          TABLE 74 NORTH AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 75 EUROPE: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 76 ASIA PACIFIC: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 77 LATIN AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 78 MIDDLE EAST & AFRICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.4.1 LIBRARY PREPARATION AND TARGET ENRICHMENT
                    6.4.1.1 Development of advanced library preparation solutions to boost growth
                                TABLE 79 LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 80 NORTH AMERICA: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 81 EUROPE: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 82 ASIA PACIFIC: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 83 LATIN AMERICA: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 84 MIDDLE EAST & AFRICA: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.4.2 QUALITY CONTROL
                    6.4.2.1 Importance of quality control in NGS workflow to drive growth
                                TABLE 85 QUALITY CONTROL MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 86 NORTH AMERICA: QUALITY CONTROL MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 87 EUROPE: QUALITY CONTROL MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 88 ASIA PACIFIC: QUALITY CONTROL MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 89 LATIN AMERICA: QUALITY CONTROL MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 90 MIDDLE EAST & AFRICA: QUALITY CONTROL MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.5 NGS PLATFORMS 
          TABLE 91 NGS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 92 NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)
          TABLE 93 NORTH AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 94 EUROPE: NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 95 ASIA PACIFIC: NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 96 LATIN AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 97 MIDDLE EAST & AFRICA: NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.5.1 ILLUMINA
                    TABLE 98 ILLUMINA NGS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 99 ILLUMINA NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)
                    6.5.1.1 NovaSeq systems
                                TABLE 100 NOVASEQ SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
                    6.5.1.2 NextSeq systems
                                TABLE 101 NEXTSEQ SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
                    6.5.1.3 MiSeq systems
                                TABLE 102 MISEQ SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
                    6.5.1.4 iSeq 100 systems
                                TABLE 103 ISEQ 100 SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
                    6.5.1.5 MiniSeq systems
                                TABLE 104 MINISEQ SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.5.2 THERMO FISHER SCIENTIFIC
                    TABLE 105 THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 106 THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.5.3 OXFORD NANOPORE TECHNOLOGIES
                    TABLE 107 OXFORD NANOPORE TECHNOLOGIES NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.5.4 PACIFIC BIOSCIENCES
                    TABLE 108 PACIFIC BIOSCIENCES NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.5.5 OTHER NGS PLATFORMS
                    TABLE 109 OTHER NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.6 BIOINFORMATICS 
          TABLE 110 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
          TABLE 111 BIOINFORMATICS MARKET, BY REGION, 2020–2027 (USD MILLION)
          TABLE 112 NORTH AMERICA: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 113 EUROPE: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 114 ASIA PACIFIC: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 115 LATIN AMERICA: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 116 MIDDLE EAST & AFRICA: BIOINFORMATICS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.6.1 NGS DATA ANALYSIS SERVICES
                    6.6.1.1 Rising awareness about NGS data analysis services to boost growth
                                TABLE 117 NGS DATA ANALYSIS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 118 NORTH AMERICA: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 119 EUROPE: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 120 ASIA PACIFIC: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 121 LATIN AMERICA: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 122 MIDDLE EAST & AFRICA: NGS DATA ANALYSIS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.6.2 NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES
                    6.6.2.1 Development of advanced bioinformatics solutions to drive growth
                                TABLE 123 NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 124 NORTH AMERICA: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 125 EUROPE: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 126 ASIA PACIFIC: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 127 LATIN AMERICA: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 128 MIDDLE EAST & AFRICA: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.6.3 NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS
                    6.6.3.1 Launch of cloud-based solutions to drive market
                                TABLE 129 NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 130 NORTH AMERICA: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 131 EUROPE: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 132 ASIA PACIFIC: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 133 LATIN AMERICA: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 134 MIDDLE EAST & AFRICA: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.7 SERVICES FOR NGS PLATFORMS 
           6.7.1 INCREASING INSTALLATION OF NGS PLATFORMS TO SUPPORT GROWTH
                    TABLE 135 SERVICES FOR NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 136 NORTH AMERICA: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 137 EUROPE: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 138 ASIA PACIFIC: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 139 LATIN AMERICA: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 140 MIDDLE EAST & AFRICA: SERVICES FOR NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)
 
7 NEXT GENERATION SEQUENCING MARKET FORECAST, BY TECHNOLOGY (Page No. - 166)
    7.1 INTRODUCTION 
          TABLE 141 NEXT-GENERATION SEQUENCING TECHNOLOGIES, BY COMPANY
          TABLE 142 NEXT GENERATION SEQUENCING INDUSTRY, BY TECHNOLOGY, 2020–2027 (USD MILLION)
    7.2 SEQUENCING BY SYNTHESIS 
           7.2.1 SBS TECHNOLOGY ENABLES HIGHEST PRODUCTION OF BASE PAIRS IN SHORT TIME PERIOD
                    TABLE 143 SEQUENCING BY SYNTHESIS MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 144 NORTH AMERICA: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 145 EUROPE: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 146 ASIA PACIFIC: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 147 LATIN AMERICA: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 148 MIDDLE EAST & AFRICA: SEQUENCING BY SYNTHESIS MARKET, BY REGION, 2020–2027 (USD MILLION)
    7.3 ION SEMICONDUCTOR SEQUENCING 
           7.3.1 SIMPLER WORKFLOW AND COST-EFFECTIVENESS ARE ADVANTAGES OF ION SEMICONDUCTOR SEQUENCING
                    TABLE 149 ION SEMICONDUCTOR SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 150 NORTH AMERICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 151 EUROPE: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 152 ASIA PACIFIC: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 153 LATIN AMERICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 154 MIDDLE EAST & AFRICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
    7.4 NANOPORE SEQUENCING 
           7.4.1 NANOPORE SEQUENCING—ONLY SEQUENCING TECHNOLOGY WITH DIRECT RNA SEQUENCING CAPABILITIES
                    TABLE 155 NANOPORE SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 156 NORTH AMERICA: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 157 EUROPE: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 158 ASIA PACIFIC: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 159 LATIN AMERICA: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 160 MIDDLE EAST & AFRICA: NANOPORE SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
    7.5 SINGLE-MOLECULE REAL-TIME SEQUENCING 
           7.5.1 SMRT SEQUENCING PRODUCES RESULTS IN SHORT TIME AND AT LOWER COSTS
                    TABLE 161 SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 162 NORTH AMERICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 163 EUROPE: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 164 ASIA PACIFIC: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 165 LATIN AMERICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 166 MIDDLE EAST & AFRICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
    7.6 OTHER SEQUENCING TECHNOLOGIES 
          TABLE 167 OTHER SEQUENCING TECHNOLOGIES MARKET, BY REGION, 2020–2027 (USD MILLION)
          TABLE 168 NORTH AMERICA: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 169 EUROPE: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 170 ASIA PACIFIC: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 171 LATIN AMERICA: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 172 MIDDLE EAST & AFRICA: OTHER SEQUENCING TECHNOLOGIES MARKET, BY REGION, 2020–2027 (USD MILLION)
 
8 NEXT GENERATION SEQUENCING MARKET FORECAST, BY APPLICATION (Page No. - 183)
    8.1 INTRODUCTION 
          TABLE 173 NEXT GENERATION SEQUENCING INDUSTRY, BY APPLICATION, 2020–2027 (USD MILLION)
    8.2 DIAGNOSTICS 
          TABLE 174 NEXT GENERATION SEQUENCING MARKET SIZE FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 175 NGS MARKET FOR DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)
          TABLE 176 NORTH AMERICA: MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 177 EUROPE: MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 178 ASIA PACIFIC: MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 179 LATIN AMERICA: MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 180 MIDDLE EAST & AFRICA: MARKET FOR DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)
           8.2.1 CANCER DIAGNOSTICS
                    8.2.1.1 High adoption of NGS in cancer diagnostics to propel growth
                                TABLE 181 NEXT GENERATION SEQUENCING MARKET RESEARCH FOR CANCER DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 182 NORTH AMERICA: MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 183 EUROPE: MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 184 ASIA PACIFIC: MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 185 LATIN AMERICA: MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 186 MIDDLE EAST & AFRICA: MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)
           8.2.2 INFECTIOUS DISEASE DIAGNOSTICS
                    8.2.2.1 Applications in infectious disease surveillance and launch of new tests to drive growth
                                TABLE 187 NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 188 NORTH AMERICA: MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 189 EUROPE: MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 190 ASIA PACIFIC: MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 191 LATIN AMERICA: MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 192 MIDDLE EAST & AFRICA: MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)
           8.2.3 REPRODUCTIVE HEALTH DIAGNOSTICS
                    8.2.3.1 Extensive use of NGS in NIPT to boost growth
                                TABLE 193 NEXT GENERATION SEQUENCING INDUSTRY FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 194 NORTH AMERICA: MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 195 EUROPE: MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 196 ASIA PACIFIC: MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 197 LATIN AMERICA: MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 198 MIDDLE EAST & AFRICA: MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)
           8.2.4 OTHER DIAGNOSTIC APPLICATIONS
                    TABLE 199 NEXT GENERATION SEQUENCING MARKET REPORT FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 200 NORTH AMERICA: MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 201 EUROPE: MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 202 ASIA PACIFIC: MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 203 LATIN AMERICA: MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 204 MIDDLE EAST & AFRICA: MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
    8.3 DRUG DISCOVERY AND DEVELOPMENT 
          TABLE 205 MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 206 MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2020–2027 (USD MILLION)
          TABLE 207 NORTH AMERICA: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 208 EUROPE: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 209 ASIA PACIFIC: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 210 LATIN AMERICA: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 211 MIDDLE EAST & AFRICA: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2020–2027 (USD MILLION)
           8.3.1 PHARMACOGENOMICS
                    8.3.1.1 Advent of NGS to understand genomic variants in humans to drive growth
                                TABLE 212 NEXT GENERATION SEQUENCING MARKET TRENDS FOR PHARMACOGENOMICS, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 213 NORTH AMERICA: MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 214 EUROPE: MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 215 ASIA PACIFIC: MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 216 LATIN AMERICA: MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 217 MIDDLE EAST & AFRICA: MARKET FOR PHARMACOGENOMICS, BY REGION, 2020–2027 (USD MILLION)
           8.3.2 OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS
                    TABLE 218 NEXT GENERATION SEQUENCING MARKET REPORT FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 219 NORTH AMERICA: MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 220 EUROPE: MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 221 ASIA PACIFIC: MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 222 LATIN AMERICA: MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 223 MIDDLE EAST & AFRICA: MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
    8.4 AGRICULTURAL AND ANIMAL RESEARCH 
           8.4.1 NGS-BASED ROUTINE SCREENING IN AGRICULTURE TO BOOST MARKET GROWTH
                    TABLE 224 MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 225 NORTH AMERICA: MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 226 EUROPE: MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 227 ASIA PACIFIC: MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 228 LATIN AMERICA: MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 229 MIDDLE EAST & AFRICA: MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY REGION, 2020–2027 (USD MILLION)
    8.5 OTHER APPLICATIONS 
          TABLE 230 MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
          TABLE 231 NORTH AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 232 EUROPE: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 233 ASIA PACIFIC: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 234 LATIN AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 235 MIDDLE EAST & AFRICA: MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
 
9 NEXT GENERATION SEQUENCING MARKET FORECAST, BY END USER (Page No. - 216)
    9.1 INTRODUCTION 
          TABLE 236 NEXT GENERATION SEQUENCING INDUSTRY, BY END USER, 2020–2027 (USD MILLION)
    9.2 ACADEMIC INSTITUTES AND RESEARCH CENTERS 
           9.2.1 ACADEMIC AND RESEARCH INSTITUTES TO ACCOUNT FOR LARGEST MARKET SHARE
                    TABLE 237 NEXT GENERATION SEQUENCING MARKET TRENDS FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 238 NORTH AMERICA: MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 239 EUROPE: MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 240 ASIA PACIFIC: MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 241 LATIN AMERICA: MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 242 MIDDLE EAST & AFRICA: MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY REGION, 2020–2027 (USD MILLION)
    9.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 
           9.3.1 GROWING COLLABORATIONS BETWEEN NGS MARKET PLAYERS AND PHARMA-BIOTECH COMPANIES TO DRIVE GROWTH
                    TABLE 243 MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 244 NORTH AMERICA: MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 245 EUROPE: MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 246 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 247 LATIN AMERICA: MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 248 MIDDLE EAST & AFRICA: MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION)
    9.4 HOSPITALS AND CLINICS 
           9.4.1 EXPANDING USE OF NGS IN HOSPITALS AND CLINICS TO BOOST GROWTH
                    TABLE 249 NGS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 250 NORTH AMERICA: MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 251 EUROPE: MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 252 ASIA PACIFIC: MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 253 LATIN AMERICA: MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 254 MIDDLE EAST & AFRICA: MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020–2027 (USD MILLION)
    9.5 REFERENCE LABORATORIES 
           9.5.1 INCREASING AVAILABILITY OF TESTING SOLUTIONS AND HIGH ADOPTION OF NGS IN REFERENCE LABORATORIES TO DRIVE GROWTH
                    TABLE 255 NEXT GENERATION SEQUENCING INDUSTRY FOR REFERENCE LABORATORIES, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 256 NORTH AMERICA: MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 257 EUROPE: MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 258 ASIA PACIFIC: MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 259 LATIN AMERICA: MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 260 MIDDLE EAST & AFRICA: MARKET FOR REFERENCE LABORATORIES, BY REGION, 2020–2027 (USD MILLION)
    9.6 OTHER END USERS 
          TABLE 261 MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)
          TABLE 262 NORTH AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 263 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 264 ASIA PACIFIC: MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 265 LATIN AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 266 MIDDLE EAST & AFRICA: MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)
 
10 NEXT GENERATION SEQUENCING MARKET, BY REGION (Page No. - 232)
     10.1 INTRODUCTION 
             TABLE 267 NEXT GENERATION SEQUENCING INDUSTRY, BY REGION, 2020–2027 (USD MILLION)
     10.2 NORTH AMERICA 
             FIGURE 30 NORTH AMERICA: NEXT GENERATION SEQUENCING MARKET SNAPSHOT
             TABLE 268 NORTH AMERICA: NEXT GENERATION SEQUENCING MARKET RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 269 NORTH AMERICA: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
             TABLE 270 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 271 NORTH AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 272 NORTH AMERICA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 273 NORTH AMERICA: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
             TABLE 274 NORTH AMERICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 275 NORTH AMERICA: MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 276 NORTH AMERICA: NGS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 277 NORTH AMERICA: NEXT GENERATION SEQUENCING INDUSTRY, BY END USER, 2020–2027 (USD MILLION)
             10.2.1 US
                        10.2.1.1 Growing R&D activities in US to drive market growth
                                      TABLE 278 US: NEXT GENERATION SEQUENCING MARKET SHARE, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 279 US: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 280 US: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 281 US: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 282 US: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                      TABLE 283 US: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 284 US: MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 285 US: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 286 US: MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Increasing government initiatives in genomics research to boost adoption of NGS
                                      TABLE 287 CANADA: NEXT GENERATION SEQUENCING MARKET OVERVIEW, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 288 CANADA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 289 CANADA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 290 CANADA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 291 CANADA: NEXT GENERATION SEQUENCING MARKET REPORT, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                      TABLE 292 CANADA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 293 CANADA: MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 294 CANADA: NGS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 295 CANADA: NEXT GENERATION SEQUENCING INDUSTRY, BY END USER, 2020–2027 (USD MILLION)
             10.2.3 NORTH AMERICA: RECESSION IMPACT
     10.3 EUROPE 
             TABLE 296 EUROPE: NEXT GENERATION SEQUENCING MARKET TRENDS, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 297 EUROPE: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
             TABLE 298 EUROPE: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 299 EUROPE: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 300 EUROPE: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 301 EUROPE: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
             TABLE 302 EUROPE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 303 EUROPE: MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 304 EUROPE: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 305 EUROPE: MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Germany dominates European NEXT GENERATION SEQUENCING MARKET
                                      TABLE 306 GERMANY: NEXT GENERATION SEQUENCING MARKET PREDICTION, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 307 GERMANY: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 308 GERMANY: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 309 GERMANY: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 310 GERMANY: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                      TABLE 311 GERMANY: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 312 GERMANY: NGS MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 313 GERMANY: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 314 GERMANY: NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2020–2027 (USD MILLION)
             10.3.2 UK
                        10.3.2.1 Strategic initiatives and funding for genomics research to support adoption of NGS
                                      TABLE 315 UK: NEXT GENERATION SEQUENCING MARKET SHARE, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 316 UK: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 317 UK: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 318 UK: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 319 UK: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                      TABLE 320 UK: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 321 UK: MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 322 UK: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 323 UK: MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 Government initiatives for genomics research to drive growth
                                      TABLE 324 FRANCE: NEXT GENERATION SEQUENCING MARKET OVERVIEW, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 325 FRANCE: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 326 FRANCE: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 327 FRANCE: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 328 FRANCE: NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                      TABLE 329 FRANCE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 330 FRANCE: NGS MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 331 FRANCE: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 332 FRANCE: NEXT GENERATION SEQUENCING INDUSTRY, BY END USER, 2020–2027 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Favorable funding scenario to drive adoption of next-generation sequencing
                                      TABLE 333 ITALY: NEXT GENERATION SEQUENCING MARKET REPORT, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 334 ITALY: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 335 ITALY: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 336 ITALY: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 337 ITALY: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                      TABLE 338 ITALY: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 339 ITALY: MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 340 ITALY: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 341 ITALY: MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.5 SPAIN
                        10.3.5.1 Focus on expanding genomic research to support growth
                                      TABLE 342 SPAIN: NEXT GENERATION SEQUENCING MARKET TRENDS, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 343 SPAIN: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 344 SPAIN: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 345 SPAIN: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 346 SPAIN: NEXT GENERATION SEQUENCING MARKET PREDICTION, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                      TABLE 347 SPAIN: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 348 SPAIN: NGS MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 349 SPAIN: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 350 SPAIN: NEXT GENERATION SEQUENCING MARKET REPORT, BY END USER, 2020–2027 (USD MILLION)
             10.3.6 NETHERLANDS
                        10.3.6.1 Focus on implementation of NGS to boost growth
                                      TABLE 351 NETHERLANDS: NEXT GENERATION SEQUENCING MARKET RESEARCH, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 352 NETHERLANDS: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 353 NETHERLANDS: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 354 NETHERLANDS: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 355 NETHERLANDS: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                      TABLE 356 NETHERLANDS: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 357 NETHERLANDS: MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 358 NETHERLANDS: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 359 NETHERLANDS: MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.7 REST OF EUROPE
                        TABLE 360 REST OF EUROPE: NEXT GENERATION SEQUENCING MARKET OVERVIEW, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                        TABLE 361 REST OF EUROPE: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 362 REST OF EUROPE: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 363 REST OF EUROPE: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 364 REST OF EUROPE: NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                        TABLE 365 REST OF EUROPE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 366 REST OF EUROPE: NGS MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 367 REST OF EUROPE: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 368 REST OF EUROPE: NEXT GENERATION SEQUENCING INDUSTRY, BY END USER, 2020–2027 (USD MILLION)
             10.3.8 EUROPE: RECESSION IMPACT
     10.4 ASIA PACIFIC 
             FIGURE 31 ASIA PACIFIC: NEXT GENERATION SEQUENCING MARKET SNAPSHOT
             TABLE 369 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 370 ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
             TABLE 371 ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 372 ASIA PACIFIC: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 373 ASIA PACIFIC: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 374 ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
             TABLE 375 ASIA PACIFIC: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 376 ASIA PACIFIC: MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 377 ASIA PACIFIC: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 378 ASIA PACIFIC: NGS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.1 CHINA
                        10.4.1.1 China to register highest growth in Asia Pacific market
                                      TABLE 379 CHINA: NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 380 CHINA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 381 CHINA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 382 CHINA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 383 CHINA: NEXT GENERATION SEQUENCING MARKET RESEARCH, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                      TABLE 384 CHINA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 385 CHINA: MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 386 CHINA: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 387 CHINA: NEXT GENERATION SEQUENCING MARKET REPORT, BY END USER, 2020–2027 (USD MILLION)
             10.4.2 JAPAN
                        10.4.2.1 Rising number of collaborations for NGS to boost market growth
                                      TABLE 388 JAPAN: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 389 JAPAN: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 390 JAPAN: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 391 JAPAN: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 392 JAPAN: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                      TABLE 393 JAPAN: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 394 JAPAN: MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 395 JAPAN: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 396 JAPAN: MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 Government initiatives for genomics to support market growth
                                      TABLE 397 INDIA: NEXT GENERATION SEQUENCING MARKET OVERVIEW, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 398 INDIA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 399 INDIA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 400 INDIA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 401 INDIA: NEXT GENERATION SEQUENCING MARKET PREDICTION, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                      TABLE 402 INDIA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 403 INDIA: NGS MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 404 INDIA: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 405 INDIA: NEXT GENERATION SEQUENCING INDUSTRY, BY END USER, 2020–2027 (USD MILLION)
             10.4.4 AUSTRALIA
                        10.4.4.1 Increasing use of NGS platforms by academic institutes to propel market growth
                                      TABLE 406 AUSTRALIA: NEXT GENERATION SEQUENCING MARKET SHARE, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 407 AUSTRALIA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 408 AUSTRALIA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 409 AUSTRALIA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 410 AUSTRALIA: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                      TABLE 411 AUSTRALIA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 412 AUSTRALIA: MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 413 AUSTRALIA: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 414 AUSTRALIA: MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.5 REST OF ASIA PACIFIC
                        TABLE 415 REST OF ASIA PACIFIC: NEXT GENERATION SEQUENCING MARKET TRENDS, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                        TABLE 416 REST OF ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 417 REST OF ASIA PACIFIC: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 418 REST OF ASIA PACIFIC: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 419 REST OF ASIA PACIFIC: NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                        TABLE 420 REST OF ASIA PACIFIC: NGS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 421 REST OF ASIA PACIFIC: MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 422 REST OF ASIA PACIFIC: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 423 REST OF ASIA PACIFIC: NEXT GENERATION SEQUENCING MARKET REPORT, BY END USER, 2020–2027 (USD MILLION)
             10.4.6 ASIA PACIFIC: RECESSION IMPACT
     10.5 LATIN AMERICA 
             TABLE 424 LATIN AMERICA: NEXT GENERATION SEQUENCING MARKET ANALYSIS, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 425 LATIN AMERICA: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
             TABLE 426 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 427 LATIN AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 428 LATIN AMERICA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 429 LATIN AMERICA: NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
             TABLE 430 LATIN AMERICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 431 LATIN AMERICA: MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 432 LATIN AMERICA: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 433 LATIN AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.5.1 BRAZIL
                        10.5.1.1 Rising focus on clinical genomics to drive demand for NGS
                                      TABLE 434 BRAZIL: NEXT GENERATION SEQUENCING MARKET DEMAND, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 435 BRAZIL: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 436 BRAZIL: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 437 BRAZIL: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 438 BRAZIL: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                      TABLE 439 BRAZIL: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 440 BRAZIL: NGS MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 441 BRAZIL: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 442 BRAZIL: NEXT GENERATION SEQUENCING INDUSTRY, BY END USER, 2020–2027 (USD MILLION)
             10.5.2 MEXICO
                        10.5.2.1 Biotechnology infrastructure development to support market growth
                                      TABLE 443 MEXICO: NEXT GENERATION SEQUENCING MARKET ANALYSIS, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 444 MEXICO: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 445 MEXICO: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 446 MEXICO: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 447 MEXICO: NEXT GENERATION SEQUENCING MARKET PREDICTION, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                      TABLE 448 MEXICO: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 449 MEXICO: MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 450 MEXICO: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 451 MEXICO: MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.5.3 REST OF LATIN AMERICA
                        TABLE 452 REST OF LATIN AMERICA: NEXT GENERATION SEQUENCING MARKET REPORT, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                        TABLE 453 REST OF LATIN AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 454 REST OF LATIN AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 455 REST OF LATIN AMERICA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 456 REST OF LATIN AMERICA: NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                        TABLE 457 REST OF LATIN AMERICA: NGS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 458 REST OF LATIN AMERICA: MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 459 REST OF LATIN AMERICA: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 460 REST OF LATIN AMERICA: NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2020–2027 (USD MILLION)
             10.5.4 LATIN AMERICA: RECESSION IMPACT
     10.6 MIDDLE EAST & AFRICA 
             TABLE 461 MIDDLE EAST & AFRICA: NEXT GENERATION SEQUENCING MARKET DEMAND, BY REGION, 2020–2027 (USD MILLION)
             TABLE 462 MIDDLE EAST & AFRICA: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
             TABLE 463 MIDDLE EAST & AFRICA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 464 MIDDLE EAST & AFRICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 465 MIDDLE EAST & AFRICA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 466 MIDDLE EAST & AFRICA: NEXT GENERATION SEQUENCING MARKET PREDICTION, BY TECHNOLOGY, 2020–2027 (USD MILLION)
             TABLE 467 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 468 MIDDLE EAST & AFRICA: MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 469 MIDDLE EAST & AFRICA: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 470 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.6.1 MIDDLE EAST
                        10.6.1.1 Expansion by prominent players and launch of genomic initiatives to support growth
                                      TABLE 471 MIDDLE EAST: NEXT GENERATION SEQUENCING MARKET ANALYSIS, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 472 MIDDLE EAST: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 473 MIDDLE EAST: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 474 MIDDLE EAST: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 475 MIDDLE EAST: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                      TABLE 476 MIDDLE EAST: NGS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 477 MIDDLE EAST: MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 478 MIDDLE EAST: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 479 MIDDLE EAST: NEXT GENERATION SEQUENCING INDUSTRY, BY END USER, 2020–2027 (USD MILLION)
             10.6.2 AFRICA
                        10.6.2.1 Collaborations among market players and government bodies to boost growth
                                      TABLE 480 AFRICA: NEXT GENERATION SEQUENCING MARKET DEMAND, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 481 AFRICA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 482 AFRICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 483 AFRICA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 484 AFRICA: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                      TABLE 485 AFRICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 486 AFRICA: MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 487 AFRICA: MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 488 AFRICA: NGS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.6.3 MIDDLE EAST & AFRICA: RECESSION IMPACT
 
11 COMPETITIVE LANDSCAPE (Page No. - 344)
     11.1 INTRODUCTION 
     11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 
             FIGURE 32 NEXT GENERATION SEQUENCING MARKET DEMAND: STRATEGIES ADOPTED
     11.3 REVENUE ANALYSIS 
             FIGURE 33 REVENUE ANALYSIS FOR KEY COMPANIES (2019–2021)
     11.4 MARKET SHARE ANALYSIS 
             FIGURE 34 NEXT GENERATION SEQUENCING INDUSTRY: MARKET SHARE ANALYSIS, BY KEY PLAYER (2021)
             TABLE 489 NEXT GENERATION SEQUENCING INDUSTRY: DEGREE OF COMPETITION
     11.5 COMPANY EVALUATION MATRIX 
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
                        FIGURE 35 NGS MARKET: COMPANY EVALUATION MATRIX, 2021
     11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 
             11.6.1 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
                        TABLE 490 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
             11.6.2 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES)
                        TABLE 491 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
             11.6.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
                        TABLE 492 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
     11.7 COMPANY EVALUATION MATRIX FOR START-UPS/SMES 
             11.7.1 PROGRESSIVE COMPANIES
             11.7.2 STARTING BLOCKS
             11.7.3 RESPONSIVE COMPANIES
             11.7.4 DYNAMIC COMPANIES
                        FIGURE 36 NGS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2021
     11.8 COMPETITIVE BENCHMARKING OF START-UPS/SMES 
             TABLE 493 NEXT GENERATION SEQUENCING MARKET: DETAILED LIST OF KEY START-UPS/SMES
             TABLE 494 NEXT GENERATION SEQUENCING MARKET DEMAND: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
     11.9 COMPETITIVE SCENARIO AND TRENDS 
             11.9.1 PRODUCT LAUNCHES
                        TABLE 495 NEXT GENERATION SEQUENCING MARKET ANALYSIS: KEY PRODUCT LAUNCHES, JANUARY 2019–DECEMBER 2022
             11.9.2 DEALS
                        TABLE 496 NEXT GENERATION SEQUENCING MARKET ANALYSIS: KEY DEALS, JANUARY 2019–DECEMBER 2022
             11.9.3 OTHER DEVELOPMENTS
                        TABLE 497 NEXT GENERATION SEQUENCING INDUSTRY: OTHER KEY DEVELOPMENTS, JANUARY 2019–DECEMBER 2022
 
12 COMPANY PROFILES (Page No. - 360)
     12.1 KEY PLAYERS 
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
             12.1.1 ILLUMINA, INC.
                        TABLE 498 ILLUMINA, INC.: BUSINESS OVERVIEW
                        FIGURE 37 ILLUMINA, INC.: COMPANY SNAPSHOT (2021)
             12.1.2 THERMO FISHER SCIENTIFIC, INC.
                        TABLE 499 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
                        FIGURE 38 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2021)
             12.1.3 PERKINELMER
                        TABLE 500 PERKINELMER: BUSINESS OVERVIEW
                        FIGURE 39 PERKINELMER: COMPANY SNAPSHOT (2021)
             12.1.4 AGILENT TECHNOLOGIES, INC.
                        TABLE 501 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
                        FIGURE 40 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2021)
             12.1.5 PACIFIC BIOSCIENCES
                        TABLE 502 PACIFIC BIOSCIENCES: BUSINESS OVERVIEW
                        FIGURE 41 PACIFIC BIOSCIENCES: COMPANY SNAPSHOT (2021)
             12.1.6 OXFORD NANOPORE TECHNOLOGIES
                        TABLE 503 OXFORD NANOPORE TECHNOLOGIES: BUSINESS OVERVIEW
                        FIGURE 42 OXFORD NANOPORE TECHNOLOGIES: COMPANY SNAPSHOT (2021)
             12.1.7 BGI GROUP
                        TABLE 504 BGI GROUP: BUSINESS OVERVIEW
             12.1.8 QIAGEN
                        TABLE 505 QIAGEN: BUSINESS OVERVIEW
                        FIGURE 43 QIAGEN: COMPANY SNAPSHOT (2021)
             12.1.9 F. HOFFMANN-LA ROCHE AG
                        TABLE 506 F. HOFFMANN-LA ROCHE AG: BUSINESS OVERVIEW
                        FIGURE 44 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2021)
             12.1.10 EUROFINS SCIENTIFIC
                        TABLE 507 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
                        FIGURE 45 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2021)
             12.1.11 BROOKS AUTOMATION, INC.
                        TABLE 508 BROOKS AUTOMATION, INC.: BUSINESS OVERVIEW
                        FIGURE 46 BROOKS AUTOMATION, INC.: COMPANY SNAPSHOT (2021)
             12.1.12 PSOMAGEN
                        TABLE 509 PSOMAGEN: BUSINESS OVERVIEW
             12.1.13 10X GENOMICS
                        TABLE 510 10X GENOMICS: BUSINESS OVERVIEW
             12.1.14 TECAN TRADING GROUP
                        TABLE 511 TECAN TRADING GROUP: BUSINESS OVERVIEW
                        FIGURE 47 TECAN GROUP: COMPANY SNAPSHOT (2021)
             12.1.15 ZYMO RESEARCH
                        TABLE 512 ZYMO RESEARCH: BUSINESS OVERVIEW
             12.1.16 TAKARA BIO
                        TABLE 513 TAKARA BIO: BUSINESS OVERVIEW
                        FIGURE 48 TAKARA BIO: COMPANY SNAPSHOT (2021)
             12.1.17 PROMEGA CORPORATION
                        TABLE 514 PROMEGA CORPORATION: BUSINESS OVERVIEW
             12.1.18 CD GENOMICS
                        TABLE 515 CD GENOMICS: BUSINESS OVERVIEW
             12.1.19 NEW ENGLAND BIOLABS
                        TABLE 516 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW
             12.1.20 NOVOGENE CORPORATION INC.
                        TABLE 517 NOVOGENE CORPORATION INC.: BUSINESS OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
     12.2 OTHER COMPANIES 
             12.2.1 HAMILTON COMPANY
             12.2.2 MEDGENOME
             12.2.3 BECTON, DICKINSON AND COMPANY
             12.2.4 COSMOSID, INC.
             12.2.5 GENOTYPIC TECHNOLOGY
             12.2.6 LGC LIMITED
 
13 APPENDIX (Page No. - 469)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 

This study involved four major activities in estimating the current size of the next generation sequencing (NGS) market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive technical, market-oriented, and commercial study of the next-generation sequencing market. The secondary sources used for this study include Press Releases, Annual Reports, White Papers, Certified Publications, Articles form authorized authors, Directories and Databases, SEC Filings, Investor Presentations, Expert Interviews, and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Next Generation Sequencing Market Size, and Share

*Others include sales managers, marketing managers, and product managers.

Note: Tiers are defined based on a company’s total revenue. As of 2021, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the next generation sequencing (NGS) market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the NGS and related products business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the global next generation sequencing (NGS) market based on the product, application, technology, end user, and region.
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities).
  • To strategically analyse micromarkets with respect to individual growth trends, future prospects, and contributions to the overall next generation sequencing (NGS) market.
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
  • To strategically profile the key players and comprehensively analyse their product portfolios, market positions, and core competencies.
  • To track and analyse competitive developments such as product launches, expansions, acquisitions, agreements, collaborations, and partnerships in the next generation sequencing (NGS) market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

  • An additional five company profiles
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 2697
Published ON
Jan, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Next Generation Sequencing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback